AI-generated summary
The authors report a case study of one patient with biopsy-proven anetoderma treated three times, three weeks apart, with a combination of 595-nm pulsed dye laser and 1550-nm non-ablative fractionated laser. They describe improved lesion color, texture and appearance after treatment, along with increased dermal elastin and less elastin fragmentation on biopsy. With only a single patient and no control group, the authors suggest the combination should be considered as a treatment option.
- Who or what was studied
- One patient with biopsy-proven anetoderma
- Wavelengths
- 595, 1550 nm
- Limits stated in the abstract
- The report describes a single patient case with no control group, so the findings cannot be generalized.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.